TRIKAFTA (COPACKAGED)
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
Approval overview TRIKAFTA (COPACKAGED) is listed in Drugs@FDA under application 217660 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR Form and strength GRANULES;ORAL - 80MG, 60MG, 40MG;59.5MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRIKAFTA (COPACKAGED) is listed in Drugs@FDA under application 217660 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR Form and strength GRANULES;ORAL - 80MG, 60MG, 40MG;59.5MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.